img

Global Low Molecular Weight Heparin API Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Low Molecular Weight Heparin API Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Low Molecular Weight Heparin (LMWH) Active Pharmaceutical Ingredient (API) refers to the biologically active component that is extracted or synthesized from heparin, a complex carbohydrate molecule derived from animal sources such as pig intestines or bovine lungs. LMWH is a modified form of heparin with a lower molecular weight, achieved by enzymatic or chemical processes. LMWH is widely used as an anticoagulant (blood thinner) in medical treatments to prevent and treat conditions such as deep vein thrombosis, pulmonary embolism, and certain cardiac conditions.
Low Molecular Weight Heparin API report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Low Molecular Weight Heparin API market is projected to reach US$ 2675.2 million in 2029, increasing from US$ 2019.4 million in 2022, with the CAGR of 7.6% during the period of 2024 to 2029. Demand from Heart Disease and Kidney Disease are the major drivers for the industry.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Low Molecular Weight Heparin API market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Shenzhen Hepalink Pharmaceutical
Yantai Dongcheng Pharmaceutical
Pfizer
Bioibérica
Changzhou Qianhong Biopharma
Nanjing King-friend Biochemical Pharmaceutical
Hebei Changshan Biochemical Pharmaceutical
Qingdao Jiulong Biopharmaceutical
Opocrin
Dongying Tiandong Pharmaceutical
Aspen Oss
Yino Pharma
Nanjing Xinbai Pharmaceutical
Hubei Enoray Biopharmaceutical
Cisen Pharmaceutical
Segment by Type
Enoxaparin Sodium
Nadroparin Calcium
Dalteparin Sodium
Others

Segment by Application


Heart Disease
Kidney Disease
Neurological Disease
Orthopedic Disease
General Surgery Diseases
Tumor Disease
Gynecological Diseases
Respiratory Diseases
Others

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Low Molecular Weight Heparin API market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Low Molecular Weight Heparin API, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Low Molecular Weight Heparin API industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Low Molecular Weight Heparin API in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Low Molecular Weight Heparin API introduction, etc. Low Molecular Weight Heparin API Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Low Molecular Weight Heparin API market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Low Molecular Weight Heparin API Market Overview
1.1 Low Molecular Weight Heparin API Product Overview
1.2 Low Molecular Weight Heparin API Market Segment by Type
1.2.1 Enoxaparin Sodium
1.2.2 Nadroparin Calcium
1.2.3 Dalteparin Sodium
1.2.4 Others
1.3 Global Low Molecular Weight Heparin API Market Size by Type
1.3.1 Global Low Molecular Weight Heparin API Market Size Overview by Type (2018-2029)
1.3.2 Global Low Molecular Weight Heparin API Historic Market Size Review by Type (2018-2024)
1.3.3 Global Low Molecular Weight Heparin API Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Low Molecular Weight Heparin API Sales Breakdown by Type (2018-2024)
1.4.2 Europe Low Molecular Weight Heparin API Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Low Molecular Weight Heparin API Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Low Molecular Weight Heparin API Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Low Molecular Weight Heparin API Sales Breakdown by Type (2018-2024)
2 Global Low Molecular Weight Heparin API Market Competition by Company
2.1 Global Top Players by Low Molecular Weight Heparin API Sales (2018-2024)
2.2 Global Top Players by Low Molecular Weight Heparin API Revenue (2018-2024)
2.3 Global Top Players by Low Molecular Weight Heparin API Price (2018-2024)
2.4 Global Top Manufacturers Low Molecular Weight Heparin API Manufacturing Base Distribution, Sales Area, Product Type
2.5 Low Molecular Weight Heparin API Market Competitive Situation and Trends
2.5.1 Low Molecular Weight Heparin API Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Low Molecular Weight Heparin API Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Low Molecular Weight Heparin API as of 2022)
2.7 Date of Key Manufacturers Enter into Low Molecular Weight Heparin API Market
2.8 Key Manufacturers Low Molecular Weight Heparin API Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Low Molecular Weight Heparin API Status and Outlook by Region
3.1 Global Low Molecular Weight Heparin API Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Low Molecular Weight Heparin API Historic Market Size by Region
3.2.1 Global Low Molecular Weight Heparin API Sales in Volume by Region (2018-2024)
3.2.2 Global Low Molecular Weight Heparin API Sales in Value by Region (2018-2024)
3.2.3 Global Low Molecular Weight Heparin API Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Low Molecular Weight Heparin API Forecasted Market Size by Region
3.3.1 Global Low Molecular Weight Heparin API Sales in Volume by Region (2024-2029)
3.3.2 Global Low Molecular Weight Heparin API Sales in Value by Region (2024-2029)
3.3.3 Global Low Molecular Weight Heparin API Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Low Molecular Weight Heparin API by Application
4.1 Low Molecular Weight Heparin API Market Segment by Application
4.1.1 Heart Disease
4.1.2 Kidney Disease
4.1.3 Neurological Disease
4.1.4 Orthopedic Disease
4.1.5 General Surgery Diseases
4.1.6 Tumor Disease
4.1.7 Gynecological Diseases
4.1.8 Respiratory Diseases
4.1.9 Others
4.2 Global Low Molecular Weight Heparin API Market Size by Application
4.2.1 Global Low Molecular Weight Heparin API Market Size Overview by Application (2018-2029)
4.2.2 Global Low Molecular Weight Heparin API Historic Market Size Review by Application (2018-2024)
4.2.3 Global Low Molecular Weight Heparin API Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Low Molecular Weight Heparin API Sales Breakdown by Application (2018-2024)
4.3.2 Europe Low Molecular Weight Heparin API Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Low Molecular Weight Heparin API Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Low Molecular Weight Heparin API Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Low Molecular Weight Heparin API Sales Breakdown by Application (2018-2024)
5 North America Low Molecular Weight Heparin API by Country
5.1 North America Low Molecular Weight Heparin API Historic Market Size by Country
5.1.1 North America Low Molecular Weight Heparin API Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Low Molecular Weight Heparin API Sales in Volume by Country (2018-2024)
5.1.3 North America Low Molecular Weight Heparin API Sales in Value by Country (2018-2024)
5.2 North America Low Molecular Weight Heparin API Forecasted Market Size by Country
5.2.1 North America Low Molecular Weight Heparin API Sales in Volume by Country (2024-2029)
5.2.2 North America Low Molecular Weight Heparin API Sales in Value by Country (2024-2029)
6 Europe Low Molecular Weight Heparin API by Country
6.1 Europe Low Molecular Weight Heparin API Historic Market Size by Country
6.1.1 Europe Low Molecular Weight Heparin API Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Low Molecular Weight Heparin API Sales in Volume by Country (2018-2024)
6.1.3 Europe Low Molecular Weight Heparin API Sales in Value by Country (2018-2024)
6.2 Europe Low Molecular Weight Heparin API Forecasted Market Size by Country
6.2.1 Europe Low Molecular Weight Heparin API Sales in Volume by Country (2024-2029)
6.2.2 Europe Low Molecular Weight Heparin API Sales in Value by Country (2024-2029)
7 Asia-Pacific Low Molecular Weight Heparin API by Region
7.1 Asia-Pacific Low Molecular Weight Heparin API Historic Market Size by Region
7.1.1 Asia-Pacific Low Molecular Weight Heparin API Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Low Molecular Weight Heparin API Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Low Molecular Weight Heparin API Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Low Molecular Weight Heparin API Forecasted Market Size by Region
7.2.1 Asia-Pacific Low Molecular Weight Heparin API Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Low Molecular Weight Heparin API Sales in Value by Region (2024-2029)
8 Latin America Low Molecular Weight Heparin API by Country
8.1 Latin America Low Molecular Weight Heparin API Historic Market Size by Country
8.1.1 Latin America Low Molecular Weight Heparin API Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Low Molecular Weight Heparin API Sales in Volume by Country (2018-2024)
8.1.3 Latin America Low Molecular Weight Heparin API Sales in Value by Country (2018-2024)
8.2 Latin America Low Molecular Weight Heparin API Forecasted Market Size by Country
8.2.1 Latin America Low Molecular Weight Heparin API Sales in Volume by Country (2024-2029)
8.2.2 Latin America Low Molecular Weight Heparin API Sales in Value by Country (2024-2029)
9 Middle East and Africa Low Molecular Weight Heparin API by Country
9.1 Middle East and Africa Low Molecular Weight Heparin API Historic Market Size by Country
9.1.1 Middle East and Africa Low Molecular Weight Heparin API Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Low Molecular Weight Heparin API Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Low Molecular Weight Heparin API Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Low Molecular Weight Heparin API Forecasted Market Size by Country
9.2.1 Middle East and Africa Low Molecular Weight Heparin API Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Low Molecular Weight Heparin API Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Shenzhen Hepalink Pharmaceutical
10.1.1 Shenzhen Hepalink Pharmaceutical Company Information
10.1.2 Shenzhen Hepalink Pharmaceutical Introduction and Business Overview
10.1.3 Shenzhen Hepalink Pharmaceutical Low Molecular Weight Heparin API Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Shenzhen Hepalink Pharmaceutical Low Molecular Weight Heparin API Products Offered
10.1.5 Shenzhen Hepalink Pharmaceutical Recent Development
10.2 Yantai Dongcheng Pharmaceutical
10.2.1 Yantai Dongcheng Pharmaceutical Company Information
10.2.2 Yantai Dongcheng Pharmaceutical Introduction and Business Overview
10.2.3 Yantai Dongcheng Pharmaceutical Low Molecular Weight Heparin API Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Yantai Dongcheng Pharmaceutical Low Molecular Weight Heparin API Products Offered
10.2.5 Yantai Dongcheng Pharmaceutical Recent Development
10.3 Pfizer
10.3.1 Pfizer Company Information
10.3.2 Pfizer Introduction and Business Overview
10.3.3 Pfizer Low Molecular Weight Heparin API Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Pfizer Low Molecular Weight Heparin API Products Offered
10.3.5 Pfizer Recent Development
10.4 Bioibérica
10.4.1 Bioibérica Company Information
10.4.2 Bioibérica Introduction and Business Overview
10.4.3 Bioibérica Low Molecular Weight Heparin API Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Bioibérica Low Molecular Weight Heparin API Products Offered
10.4.5 Bioibérica Recent Development
10.5 Changzhou Qianhong Biopharma
10.5.1 Changzhou Qianhong Biopharma Company Information
10.5.2 Changzhou Qianhong Biopharma Introduction and Business Overview
10.5.3 Changzhou Qianhong Biopharma Low Molecular Weight Heparin API Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Changzhou Qianhong Biopharma Low Molecular Weight Heparin API Products Offered
10.5.5 Changzhou Qianhong Biopharma Recent Development
10.6 Nanjing King-friend Biochemical Pharmaceutical
10.6.1 Nanjing King-friend Biochemical Pharmaceutical Company Information
10.6.2 Nanjing King-friend Biochemical Pharmaceutical Introduction and Business Overview
10.6.3 Nanjing King-friend Biochemical Pharmaceutical Low Molecular Weight Heparin API Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Nanjing King-friend Biochemical Pharmaceutical Low Molecular Weight Heparin API Products Offered
10.6.5 Nanjing King-friend Biochemical Pharmaceutical Recent Development
10.7 Hebei Changshan Biochemical Pharmaceutical
10.7.1 Hebei Changshan Biochemical Pharmaceutical Company Information
10.7.2 Hebei Changshan Biochemical Pharmaceutical Introduction and Business Overview
10.7.3 Hebei Changshan Biochemical Pharmaceutical Low Molecular Weight Heparin API Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Hebei Changshan Biochemical Pharmaceutical Low Molecular Weight Heparin API Products Offered
10.7.5 Hebei Changshan Biochemical Pharmaceutical Recent Development
10.8 Qingdao Jiulong Biopharmaceutical
10.8.1 Qingdao Jiulong Biopharmaceutical Company Information
10.8.2 Qingdao Jiulong Biopharmaceutical Introduction and Business Overview
10.8.3 Qingdao Jiulong Biopharmaceutical Low Molecular Weight Heparin API Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Qingdao Jiulong Biopharmaceutical Low Molecular Weight Heparin API Products Offered
10.8.5 Qingdao Jiulong Biopharmaceutical Recent Development
10.9 Opocrin
10.9.1 Opocrin Company Information
10.9.2 Opocrin Introduction and Business Overview
10.9.3 Opocrin Low Molecular Weight Heparin API Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Opocrin Low Molecular Weight Heparin API Products Offered
10.9.5 Opocrin Recent Development
10.10 Dongying Tiandong Pharmaceutical
10.10.1 Dongying Tiandong Pharmaceutical Company Information
10.10.2 Dongying Tiandong Pharmaceutical Introduction and Business Overview
10.10.3 Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin API Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin API Products Offered
10.10.5 Dongying Tiandong Pharmaceutical Recent Development
10.11 Aspen Oss
10.11.1 Aspen Oss Company Information
10.11.2 Aspen Oss Introduction and Business Overview
10.11.3 Aspen Oss Low Molecular Weight Heparin API Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Aspen Oss Low Molecular Weight Heparin API Products Offered
10.11.5 Aspen Oss Recent Development
10.12 Yino Pharma
10.12.1 Yino Pharma Company Information
10.12.2 Yino Pharma Introduction and Business Overview
10.12.3 Yino Pharma Low Molecular Weight Heparin API Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Yino Pharma Low Molecular Weight Heparin API Products Offered
10.12.5 Yino Pharma Recent Development
10.13 Nanjing Xinbai Pharmaceutical
10.13.1 Nanjing Xinbai Pharmaceutical Company Information
10.13.2 Nanjing Xinbai Pharmaceutical Introduction and Business Overview
10.13.3 Nanjing Xinbai Pharmaceutical Low Molecular Weight Heparin API Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Nanjing Xinbai Pharmaceutical Low Molecular Weight Heparin API Products Offered
10.13.5 Nanjing Xinbai Pharmaceutical Recent Development
10.14 Hubei Enoray Biopharmaceutical
10.14.1 Hubei Enoray Biopharmaceutical Company Information
10.14.2 Hubei Enoray Biopharmaceutical Introduction and Business Overview
10.14.3 Hubei Enoray Biopharmaceutical Low Molecular Weight Heparin API Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Hubei Enoray Biopharmaceutical Low Molecular Weight Heparin API Products Offered
10.14.5 Hubei Enoray Biopharmaceutical Recent Development
10.15 Cisen Pharmaceutical
10.15.1 Cisen Pharmaceutical Company Information
10.15.2 Cisen Pharmaceutical Introduction and Business Overview
10.15.3 Cisen Pharmaceutical Low Molecular Weight Heparin API Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Cisen Pharmaceutical Low Molecular Weight Heparin API Products Offered
10.15.5 Cisen Pharmaceutical Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Low Molecular Weight Heparin API Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Low Molecular Weight Heparin API Industrial Chain Analysis
11.4 Low Molecular Weight Heparin API Market Dynamics
11.4.1 Low Molecular Weight Heparin API Industry Trends
11.4.2 Low Molecular Weight Heparin API Market Drivers
11.4.3 Low Molecular Weight Heparin API Market Challenges
11.4.4 Low Molecular Weight Heparin API Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Low Molecular Weight Heparin API Distributors
12.3 Low Molecular Weight Heparin API Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Enoxaparin Sodium
Table 2. Major Company of Nadroparin Calcium
Table 3. Major Company of Dalteparin Sodium
Table 4. Major Company of Others
Table 5. Global Low Molecular Weight Heparin API Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Low Molecular Weight Heparin API Sales by Type (2018-2024) & (Billion Units)
Table 7. Global Low Molecular Weight Heparin API Sales Market Share in Volume by Type (2018-2024)
Table 8. Global Low Molecular Weight Heparin API Sales by Type (2018-2024) & (US& Million)
Table 9. Global Low Molecular Weight Heparin API Market Share in Value by Type (2018-2024)
Table 10. Global Low Molecular Weight Heparin API Price by Type (2018-2024) & (US$/Billion Untis)
Table 11. Global Low Molecular Weight Heparin API Sales by Type (2024-2029) & (Billion Units)
Table 12. Global Low Molecular Weight Heparin API Sales Market Share in Volume by Type (2024-2029)
Table 13. Global Low Molecular Weight Heparin API Sales by Type (2024-2029) & (US$ Million)
Table 14. Global Low Molecular Weight Heparin API Sales Market Share in Value by Type (2024-2029)
Table 15. Global Low Molecular Weight Heparin API Price by Type (2024-2029) & (US$/Billion Untis)
Table 16. North America Low Molecular Weight Heparin API Sales by Type (2018-2024) & (Billion Units)
Table 17. North America Low Molecular Weight Heparin API Sales by Type (2018-2024) & (US$ Million)
Table 18. Europe Low Molecular Weight Heparin API Sales (Billion Units) by Type (2018-2024)
Table 19. Europe Low Molecular Weight Heparin API Sales by Type (2018-2024) & (US$ Million)
Table 20. Asia-Pacific Low Molecular Weight Heparin API Sales (Billion Units) by Type (2018-2024)
Table 21. Asia-Pacific Low Molecular Weight Heparin API Sales by Type (2018-2024) & (US$ Million)
Table 22. Latin America Low Molecular Weight Heparin API Sales (Billion Units) by Type (2018-2024)
Table 23. Latin America Low Molecular Weight Heparin API Sales by Type (2018-2024) & (US$ Million)
Table 24. Middle East and Africa Low Molecular Weight Heparin API Sales (Billion Units) by Type (2018-2024)
Table 25. Middle East and Africa Low Molecular Weight Heparin API Sales by Type (2018-2024) & (US$ Million)
Table 26. Global Low Molecular Weight Heparin API Sales by Company (2018-2024) & (Billion Units)
Table 27. Global Low Molecular Weight Heparin API Sales Share by Company (2018-2024)
Table 28. Global Low Molecular Weight Heparin API Revenue by Company (2018-2024) & (US$ Million)
Table 29. Global Low Molecular Weight Heparin API Revenue Share by Company (2018-2024)
Table 30. Global Market Low Molecular Weight Heparin API Price by Company (2018-2024) & (US$/Billion Untis)
Table 31. Global Low Molecular Weight Heparin API Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Low Molecular Weight Heparin API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Low Molecular Weight Heparin API as of 2022)
Table 34. Date of Key Manufacturers Enter into Low Molecular Weight Heparin API Market
Table 35. Key Manufacturers Low Molecular Weight Heparin API Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Low Molecular Weight Heparin API Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Global Low Molecular Weight Heparin API Sales by Region (2018-2024) & (Billion Units)
Table 39. Global Low Molecular Weight Heparin API Sales Market Share in Volume by Region (2018-2024)
Table 40. Global Low Molecular Weight Heparin API Sales by Region (2018-2024) & (US$ Million)
Table 41. Global Low Molecular Weight Heparin API Sales Market Share in Value by Region (2018-2024)
Table 42. Global Low Molecular Weight Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Untis) and Gross Margin (2018-2024)
Table 43. Global Low Molecular Weight Heparin API Sales by Region (2024-2029) & (Billion Units)
Table 44. Global Low Molecular Weight Heparin API Sales Market Share in Volume by Region (2024-2029)
Table 45. Global Low Molecular Weight Heparin API Sales by Region (2024-2029) & (US$ Million)
Table 46. Global Low Molecular Weight Heparin API Sales Market Share in Value by Region (2024-2029)
Table 47. Global Low Molecular Weight Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Untis) and Gross Margin (2024-2029)
Table 48. Global Low Molecular Weight Heparin API Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 49. Global Low Molecular Weight Heparin API Sales by Application (2018-2024) & (Billion Units)
Table 50. Global Low Molecular Weight Heparin API Sales Market Share in Volume by Application (2018-2024)
Table 51. Global Low Molecular Weight Heparin API Sales by Application (2018-2024) & (US$ Million)
Table 52. Global Low Molecular Weight Heparin API Sales Market Share in Value by Application (2018-2024)
Table 53. Global Low Molecular Weight Heparin API Price by Application (2018-2024) & (US$/Billion Untis)
Table 54. Global Low Molecular Weight Heparin API Sales by Application (2024-2029) & (Billion Units)
Table 55. Global Low Molecular Weight Heparin API Sales Market Share in Volume by Application (2024-2029)
Table 56. Global Low Molecular Weight Heparin API Sales by Application (2024-2029) & (US$ Million)
Table 57. Global Low Molecular Weight Heparin API Sales Market Share in Value by Application (2024-2029)
Table 58. Global Low Molecular Weight Heparin API Price by Application (2024-2029) & (US$/Billion Untis)
Table 59. North America Low Molecular Weight Heparin API Sales by Application (2018-2024) (Billion Units)
Table 60. North America Low Molecular Weight Heparin API Sales by Application (2018-2024) & (US$ Million)
Table 61. Europe Low Molecular Weight Heparin API Sales by Application (2018-2024) (Billion Units)
Table 62. Europe Low Molecular Weight Heparin API Sales by Application (2018-2024) & (US$ Million)
Table 63. Asia-Pacific Low Molecular Weight Heparin API Sales by Application (2018-2024) (Billion Units)
Table 64. Asia-Pacific Low Molecular Weight Heparin API Sales by Application (2018-2024) & (US$ Million)
Table 65. Latin America Low Molecular Weight Heparin API Sales by Application (2018-2024) (Billion Units)
Table 66. Latin America Low Molecular Weight Heparin API Sales by Application (2018-2024) & (US$ Million)
Table 67. Middle East and Africa Low Molecular Weight Heparin API Sales by Application (2018-2024) (Billion Units)
Table 68. Middle East and Africa Low Molecular Weight Heparin API Sales by Application (2018-2024) & (US$ Million)
Table 69. North America Low Molecular Weight Heparin API Sales by Country (2018-2024) & (Billion Units)
Table 70. North America Low Molecular Weight Heparin API Sales Market Share in Volume by Country (2018-2024)
Table 71. North America Low Molecular Weight Heparin API Sales by Country (2018-2024) & (US$ Million)
Table 72. North America Low Molecular Weight Heparin API Sales Market Share in Value by Country (2018-2024)
Table 73. North America Low Molecular Weight Heparin API Sales by Country (2024-2029) & (Billion Units)
Table 74. North America Low Molecular Weight Heparin API Sales Market Share in Volume by Country (2024-2029)
Table 75. North America Low Molecular Weight Heparin API Sales by Country (2024-2029) & (US$ Million)
Table 76. North America Low Molecular Weight Heparin API Sales Market Share in Value by Country (2024-2029)
Table 77. Europe Low Molecular Weight Heparin API Sales by Country (2018-2024) & (Billion Units)
Table 78. Europe Low Molecular Weight Heparin API Sales Market Share in Volume by Country (2018-2024)
Table 79. Europe Low Molecular Weight Heparin API Sales by Country (2018-2024) & (US$ Million)
Table 80. Europe Low Molecular Weight Heparin API Sales Market Share in Value by Country (2018-2024)
Table 81. Europe Low Molecular Weight Heparin API Sales by Country (2024-2029) & (Billion Units)
Table 82. Europe Low Molecular Weight Heparin API Sales Market Share in Volume by Country (2024-2029)
Table 83. Europe Low Molecular Weight Heparin API Sales by Country (2024-2029) & (US$ Million)
Table 84. Europe Low Molecular Weight Heparin API Sales Market Share in Value by Country (2024-2029)
Table 85. Asia-Pacific Low Molecular Weight Heparin API Sales by Region (2018-2024) & (Billion Units)
Table 86. Asia-Pacific Low Molecular Weight Heparin API Sales Market Share in Volume by Region (2018-2024)
Table 87. Asia-Pacific Low Molecular Weight Heparin API Sales by Region (2018-2024) & (US$ Million)
Table 88. Asia-Pacific Low Molecular Weight Heparin API Sales Market Share in Value by Region (2018-2024)
Table 89. Asia-Pacific Low Molecular Weight Heparin API Sales by Region (2024-2029) & (Billion Units)
Table 90. Asia-Pacific Low Molecular Weight Heparin API Sales Market Share in Volume by Region (2024-2029)
Table 91. Asia-Pacific Low Molecular Weight Heparin API Sales by Region (2024-2029) & (US$ Million)
Table 92. Asia-Pacific Low Molecular Weight Heparin API Sales Market Share in Value by Region (2024-2029)
Table 93. Latin America Low Molecular Weight Heparin API Sales by Country (2018-2024) & (Billion Units)
Table 94. Latin America Low Molecular Weight Heparin API Sales Market Share in Volume by Country (2018-2024)
Table 95. Latin America Low Molecular Weight Heparin API Sales by Country (2018-2024) & (US$ Million)
Table 96. Latin America Low Molecular Weight Heparin API Sales Market Share in Value by Country (2018-2024)
Table 97. Latin America Low Molecular Weight Heparin API Sales by Country (2024-2029) & (Billion Units)
Table 98. Latin America Low Molecular Weight Heparin API Sales Market Share in Volume by Country (2024-2029)
Table 99. Latin America Low Molecular Weight Heparin API Sales by Country (2024-2029) & (US$ Million)
Table 100. Latin America Low Molecular Weight Heparin API Sales Market Share in Value by Country (2024-2029)
Table 101. Middle East and Africa Low Molecular Weight Heparin API Sales by Country (2018-2024) & (Billion Units)
Table 102. Middle East and Africa Low Molecular Weight Heparin API Sales Market Share in Volume by Country (2018-2024)
Table 103. Middle East and Africa Low Molecular Weight Heparin API Sales by Country (2018-2024) & (US$ Million)
Table 104. Middle East and Africa Low Molecular Weight Heparin API Sales Market Share in Value by Country (2018-2024)
Table 105. Middle East and Africa Low Molecular Weight Heparin API Sales by Country (2024-2029) & (Billion Units)
Table 106. Middle East and Africa Low Molecular Weight Heparin API Sales Market Share in Volume by Country (2024-2029)
Table 107. Middle East and Africa Low Molecular Weight Heparin API Sales by Country (2024-2029) & (US$ Million)
Table 108. Middle East and Africa Low Molecular Weight Heparin API Sales Market Share in Value by Country (2024-2029)
Table 109. Shenzhen Hepalink Pharmaceutical Company Information
Table 110. Shenzhen Hepalink Pharmaceutical Introduction and Business Overview
Table 111. Shenzhen Hepalink Pharmaceutical Low Molecular Weight Heparin API Sales (Billion Units), Revenue (Million USD), Price (US$/Billion Untis) and Gross Margin (2018-2024)
Table 112. Shenzhen Hepalink Pharmaceutical Low Molecular Weight Heparin API Product
Table 113. Shenzhen Hepalink Pharmaceutical Recent Development
Table 114. Yantai Dongcheng Pharmaceutical Company Information
Table 115. Yantai Dongcheng Pharmaceutical Introduction and Business Overview
Table 116. Yantai Dongcheng Pharmaceutical Low Molecular Weight Heparin API Sales (Billion Units), Revenue (Million USD), Price (US$/Billion Untis) and Gross Margin (2018-2024)
Table 117. Yantai Dongcheng Pharmaceutical Low Molecular Weight Heparin API Product
Table 118. Yantai Dongcheng Pharmaceutical Recent Development
Table 119. Pfizer Company Information
Table 120. Pfizer Introduction and Business Overview
Table 121. Pfizer Low Molecular Weight Heparin API Sales (Billion Units), Revenue (Million USD), Price (US$/Billion Untis) and Gross Margin (2018-2024)
Table 122. Pfizer Low Molecular Weight Heparin API Product
Table 123. Pfizer Recent Development
Table 124. Bioibérica Company Information
Table 125. Bioibérica Introduction and Business Overview
Table 126. Bioibérica Low Molecular Weight Heparin API Sales (Billion Units), Revenue (Million USD), Price (US$/Billion Untis) and Gross Margin (2018-2024)
Table 127. Bioibérica Low Molecular Weight Heparin API Product
Table 128. Bioibérica Recent Development
Table 129. Changzhou Qianhong Biopharma Company Information
Table 130. Changzhou Qianhong Biopharma Introduction and Business Overview
Table 131. Changzhou Qianhong Biopharma Low Molecular Weight Heparin API Sales (Billion Units), Revenue (Million USD), Price (US$/Billion Untis) and Gross Margin (2018-2024)
Table 132. Changzhou Qianhong Biopharma Low Molecular Weight Heparin API Product
Table 133. Changzhou Qianhong Biopharma Recent Development
Table 134. Nanjing King-friend Biochemical Pharmaceutical Company Information
Table 135. Nanjing King-friend Biochemical Pharmaceutical Introduction and Business Overview
Table 136. Nanjing King-friend Biochemical Pharmaceutical Low Molecular Weight Heparin API Sales (Billion Units), Revenue (Million USD), Price (US$/Billion Untis) and Gross Margin (2018-2024)
Table 137. Nanjing King-friend Biochemical Pharmaceutical Low Molecular Weight Heparin API Product
Table 138. Nanjing King-friend Biochemical Pharmaceutical Recent Development
Table 139. Hebei Changshan Biochemical Pharmaceutical Company Information
Table 140. Hebei Changshan Biochemical Pharmaceutical Introduction and Business Overview
Table 141. Hebei Changshan Biochemical Pharmaceutical Low Molecular Weight Heparin API Sales (Billion Units), Revenue (Million USD), Price (US$/Billion Untis) and Gross Margin (2018-2024)
Table 142. Hebei Changshan Biochemical Pharmaceutical Low Molecular Weight Heparin API Product
Table 143. Hebei Changshan Biochemical Pharmaceutical Recent Development
Table 144. Qingdao Jiulong Biopharmaceutical Company Information
Table 145. Qingdao Jiulong Biopharmaceutical Introduction and Business Overview
Table 146. Qingdao Jiulong Biopharmaceutical Low Molecular Weight Heparin API Sales (Billion Units), Revenue (Million USD), Price (US$/Billion Untis) and Gross Margin (2018-2024)
Table 147. Qingdao Jiulong Biopharmaceutical Low Molecular Weight Heparin API Product
Table 148. Qingdao Jiulong Biopharmaceutical Recent Development
Table 149. Opocrin Company Information
Table 150. Opocrin Introduction and Business Overview
Table 151. Opocrin Low Molecular Weight Heparin API Sales (Billion Units), Revenue (Million USD), Price (US$/Billion Untis) and Gross Margin (2018-2024)
Table 152. Opocrin Low Molecular Weight Heparin API Product
Table 153. Opocrin Recent Development
Table 154. Dongying Tiandong Pharmaceutical Company Information
Table 155. Dongying Tiandong Pharmaceutical Introduction and Business Overview
Table 156. Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin API Sales (Billion Units), Revenue (Million USD), Price (US$/Billion Untis) and Gross Margin (2018-2024)
Table 157. Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin API Product
Table 158. Dongying Tiandong Pharmaceutical Recent Development
Table 159. Aspen Oss Company Information
Table 160. Aspen Oss Introduction and Business Overview
Table 161. Aspen Oss Low Molecular Weight Heparin API Sales (Billion Units), Revenue (Million USD), Price (US$/Billion Untis) and Gross Margin (2018-2024)
Table 162. Aspen Oss Low Molecular Weight Heparin API Product
Table 163. Aspen Oss Recent Development
Table 164. Yino Pharma Company Information
Table 165. Yino Pharma Introduction and Business Overview
Table 166. Yino Pharma Low Molecular Weight Heparin API Sales (Billion Units), Revenue (Million USD), Price (US$/Billion Untis) and Gross Margin (2018-2024)
Table 167. Yino Pharma Low Molecular Weight Heparin API Product
Table 168. Yino Pharma Recent Development
Table 169. Nanjing Xinbai Pharmaceutical Company Information
Table 170. Nanjing Xinbai Pharmaceutical Introduction and Business Overview
Table 171. Nanjing Xinbai Pharmaceutical Low Molecular Weight Heparin API Sales (Billion Units), Revenue (Million USD), Price (US$/Billion Untis) and Gross Margin (2018-2024)
Table 172. Nanjing Xinbai Pharmaceutical Low Molecular Weight Heparin API Product
Table 173. Nanjing Xinbai Pharmaceutical Recent Development
Table 174. Hubei Enoray Biopharmaceutical Company Information
Table 175. Hubei Enoray Biopharmaceutical Introduction and Business Overview
Table 176. Hubei Enoray Biopharmaceutical Low Molecular Weight Heparin API Sales (Billion Units), Revenue (Million USD), Price (US$/Billion Untis) and Gross Margin (2018-2024)
Table 177. Hubei Enoray Biopharmaceutical Low Molecular Weight Heparin API Product
Table 178. Hubei Enoray Biopharmaceutical Recent Development
Table 179. Cisen Pharmaceutical Company Information
Table 180. Cisen Pharmaceutical Introduction and Business Overview
Table 181. Cisen Pharmaceutical Low Molecular Weight Heparin API Sales (Billion Units), Revenue (Million USD), Price (US$/Billion Untis) and Gross Margin (2018-2024)
Table 182. Cisen Pharmaceutical Low Molecular Weight Heparin API Product
Table 183. Cisen Pharmaceutical Recent Development
Table 184. Key Raw Materials Lists
Table 185. Raw Materials Key Suppliers Lists
Table 186. Low Molecular Weight Heparin API Market Trends
Table 187. Low Molecular Weight Heparin API Market Drivers
Table 188. Low Molecular Weight Heparin API Market Challenges
Table 189. Low Molecular Weight Heparin API Market Restraints
Table 190. Low Molecular Weight Heparin API Distributors List
Table 191. Low Molecular Weight Heparin API Downstream Customers
Table 192. Research Programs/Design for This Report
Table 193. Key Data Information from Secondary Sources
Table 194. Key Data Information from Primary Sources
List of Figures
Figure 1. Low Molecular Weight Heparin API Product Picture
Figure 2. Global Low Molecular Weight Heparin API Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Low Molecular Weight Heparin API Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Low Molecular Weight Heparin API Sales Status and Outlook (2018-2029) & (Billion Units)
Figure 5. Product Picture of Enoxaparin Sodium
Figure 6. Global Enoxaparin Sodium Sales YoY Growth (2018-2029) & (Billion Units)
Figure 7. Product Picture of Nadroparin Calcium
Figure 8. Global Nadroparin Calcium Sales YoY Growth (2018-2029) & (Billion Units)
Figure 9. Product Picture of Dalteparin Sodium
Figure 10. Global Dalteparin Sodium Sales YoY Growth (2018-2029) & (Billion Units)
Figure 11. Product Picture of Others
Figure 12. Global Others Sales YoY Growth (2018-2029) & (Billion Units)
Figure 13. Global Low Molecular Weight Heparin API Sales by Type (2018-2029) & (US$ Million)
Figure 14. Global Low Molecular Weight Heparin API Sales Market Share by Type in 2022 & 2029
Figure 15. North America Low Molecular Weight Heparin API Sales Market Share in Volume by Type in 2022
Figure 16. North America Low Molecular Weight Heparin API Sales Market Share in Value by Type in 2022
Figure 17. Europe Low Molecular Weight Heparin API Sales Market Share in Volume by Type in 2022
Figure 18. Europe Low Molecular Weight Heparin API Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Low Molecular Weight Heparin API Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Low Molecular Weight Heparin API Sales Market Share in Value by Type in 2022
Figure 21. Latin America Low Molecular Weight Heparin API Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Low Molecular Weight Heparin API Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Low Molecular Weight Heparin API Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Low Molecular Weight Heparin API Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Low Molecular Weight Heparin API Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Low Molecular Weight Heparin API Revenue in 2022
Figure 27. Low Molecular Weight Heparin API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of Heart Disease
Figure 29. Global Heart Disease Sales YoY Growth (2018-2029) & (Billion Units)
Figure 30. Product Picture of Kidney Disease
Figure 31. Global Kidney Disease Sales YoY Growth (2018-2029) & (Billion Units)
Figure 32. Product Picture of Neurological Disease
Figure 33. Global Neurological Disease Sales YoY Growth (2018-2029) & (Billion Units)
Figure 34. Product Picture of Orthopedic Disease
Figure 35. Global Orthopedic Disease Sales YoY Growth (2018-2029) & (Billion Units)
Figure 36. Product Picture of General Surgery Diseases
Figure 37. Global General Surgery Diseases Sales YoY Growth (2018-2029) & (Billion Units)
Figure 38. Product Picture of Tumor Disease
Figure 39. Global Tumor Disease Sales YoY Growth (2018-2029) & (Billion Units)
Figure 40. Product Picture of Gynecological Diseases
Figure 41. Global Gynecological Diseases Sales YoY Growth (2018-2029) & (Billion Units)
Figure 42. Product Picture of Respiratory Diseases
Figure 43. Global Respiratory Diseases Sales YoY Growth (2018-2029) & (Billion Units)
Figure 44. Product Picture of Others
Figure 45. Global Others Sales YoY Growth (2018-2029) & (Billion Units)
Figure 46. Global Low Molecular Weight Heparin API Sales by Application (2018-2029) & (US$ Million)
Figure 47. Global Low Molecular Weight Heparin API Sales Market Share by Application in 2022 & 2029
Figure 48. North America Low Molecular Weight Heparin API Sales Market Share in Volume by Application in 2022
Figure 49. North America Low Molecular Weight Heparin API Sales Market Share in Value by Application in 2022
Figure 50. Europe Low Molecular Weight Heparin API Sales Market Share in Volume by Application in 2022
Figure 51. Europe Low Molecular Weight Heparin API Sales Market Share in Value by Application in 2022
Figure 52. Asia-Pacific Low Molecular Weight Heparin API Sales Market Share in Volume by Application in 2022
Figure 53. Asia-Pacific Low Molecular Weight Heparin API Sales Market Share in Value by Application in 2022
Figure 54. Latin America Low Molecular Weight Heparin API Sales Market Share in Volume by Application in 2022
Figure 55. Latin America Low Molecular Weight Heparin API Sales Market Share in Value by Application in 2022
Figure 56. Middle East and Africa Low Molecular Weight Heparin API Sales Market Share in Value by Application in 2022
Figure 57. Key Raw Materials Price
Figure 58. Low Molecular Weight Heparin API Manufacturing Cost Structure
Figure 59. Low Molecular Weight Heparin API Industrial Chain Analysis
Figure 60. Channels of Distribution
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries